Use of Intravitreal Ganciclovir as Monotherapy for Bilateral CMV Retinitis in a Tertiary Government Hospital

Abstract

In a tertiary government hospital where cost is an invariable concern, this report validates monotherapy of intravitreal ganciclovir as an effective option for patients due to affordability and ease of administration compared to systemic therapy. The case also exhibits the potential of intravitreal therapy to improve visual acuity in advance bilateral retinal disease